Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual Glioma”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04164901
What this trial is testing

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

Who this might be right for
Grade 2 GliomaResidual GliomaRecurrent Glioma
Institut de Recherches Internationales Servier 331
Very early researchLooking for participantsNCT07025226
What this trial is testing

Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease

Who this might be right for
Glioma
Mayo Clinic 10
Testing effectiveness (Phase 2)Looking for participantsNCT05734560
What this trial is testing

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Who this might be right for
Newly Diagnosed MGMT Unmethylated Glioblastoma
Darell Bigner 50
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Early research (Phase 1)Study completedNCT00025558
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Early research (Phase 1)Ended earlyNCT01009866
What this trial is testing

Study of Immunotoxin, MR1-1

Who this might be right for
Supratentorial Malignant Brain Tumor
Darell D. Bigner, MD, PhD 9
Not applicableStudy completedNCT00780819
What this trial is testing

Borderzone Sampling

Who this might be right for
High Grade GliomaGlioblastoma
Maastricht University Medical Center 10
Not applicableLooking for participantsNCT04274283
What this trial is testing

Tessa Jowell BRAIN MATRIX - Platform Study

Who this might be right for
Glioma
University of Birmingham 1,000
Testing effectiveness (Phase 2)Study completedNCT00003474
What this trial is testing

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of the Brain
Burzynski Research Institute 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346157
What this trial is testing

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Who this might be right for
MedulloblastomaMedulloblastoma, ChildhoodMedulloblastoma Recurrent
Sabine Mueller, MD, PhD 69
Large-scale testing (Phase 3)Active Not RecruitingNCT06780930
What this trial is testing

Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation

Who this might be right for
Residual or Recurrent Grade 2 IDH Mutant Glioma
Servier 57
Testing effectiveness (Phase 2)Study completedNCT00752323
What this trial is testing

Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Andrew Sloan, MD 73
Not applicableUnknownNCT05850377
What this trial is testing

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Who this might be right for
High Grade GliomaGliomaGlioma, Malignant+8 more
Sociedad de Lucha Contra el Cáncer del Ecuador 90
Not applicableTemporarily pausedNCT03055208
What this trial is testing

Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Universitätsmedizin Mannheim 50
Early research (Phase 1)Ended earlyNCT02209376
What this trial is testing

Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma

Who this might be right for
Patients With Residual or Reccurent EGFRvIII+ Glioma
University of Pennsylvania 11
Testing effectiveness (Phase 2)Ended earlyNCT01088035
What this trial is testing

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Who this might be right for
Ependymoma
Ann & Robert H Lurie Children's Hospital of Chicago 75
Testing effectiveness (Phase 2)Study completedNCT00301418
What this trial is testing

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 11
Not applicableNot Yet RecruitingNCT07219199
What this trial is testing

Residual IDH1-Mutant Tumor Cell Quantification Study

Who this might be right for
Glioma
NYU Langone Health 105